UMC119-10

N/A

Report date: 2025/01/26 16:42:31

Base Information

Drug NameUMC119-10

Drug Alias Namehuman umbilical cord-derived mesenchymal stem cell therapy (Meridigen Biotech)UMC119-10

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCerebral Palsy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMeridigen Biotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesMeridigen Biotech Co Ltd

Inactive CompaniesN/A

Active IndicationsCerebral Palsy

Inactive IndicationsN/A

Other Information

ATC CodeN/A